Michigan Biomedical Venture Fund

The University of Michigan's Innovation Partnerships manages several initiatives to support startups emerging from university research, focusing on areas like life sciences, technology, and advanced manufacturing. A key part of this ecosystem is the Michigan Biomedical Venture Fund (MBVF), which invests in early-stage companies developing therapeutics, diagnostics, medical devices, and health IT solutions based on U-M licensed intellectual property. Collaborating with the College of Engineering and the Fast Forward Medical Innovation (FFMI) program, MBVF aims to drive commercialization and enhance Michigan's role in healthcare innovation. In addition, the Michigan University Innovation Capital Fund (MUICF) provides pre-seed funding to startups originating from across Michigan’s public universities. With $5 million under management, the fund is designed to help companies navigate their early stages by providing capital, strategic guidance, and networking opportunities. The fund is part of a broader consortium that unites tech transfer offices from institutions like Michigan State, Wayne State, and Western Michigan, aiming to accelerate the commercialization of university research and foster statewide economic growth. Overall, the University of Michigan's ventures are structured to bridge the gap between academia and industry, ensuring that innovative research translates into impactful, commercially viable solutions. These efforts are backed by funding from the Michigan Economic Development Corporation, reinforcing the university's commitment to driving innovation and supporting the local economy.